Products
Azur Pharma's portfolio comprises of CNS products including FazaClo®, Prialt®, women's health and urology products including Elestrin®, and an orphan disease product, Gastrocom®. FazaClo® is an antipsychotic drug indicated for the management of severely ill schizophrenic patients who fail to respond to standard treatments. FazaClo® also is indicated for reduction in the risk of recurrent suicidal behaviour in schizophrenia or schizoaffective disorders. Prialt® is indicated for the management of sever chronic pain in patients for whom intrathecal (IT) therapy is warranted, and who are intolerant of or refractory to other treatments. Elestrin® is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause. Gastrocrom® is indicated for the management of patients with mastocytosis.
